Skip to main content

Acute Pericarditis

Acute Pericarditis

Acute Pericarditis – A Complete Clinical Guide for Practice

Definition

Acute pericarditis is an inflammatory condition of the pericardium lasting less than 4–6 weeks. It is a common cause of acute chest pain and should always be differentiated from acute coronary syndromes.


Epidemiology

Acute pericarditis accounts for approximately 5% of emergency department visits for chest pain not related to myocardial infarction. It affects all age groups, with a slight male predominance.


Etiology

In most cases, acute pericarditis is idiopathic, presumed viral. Common causes include:

• Viral: Coxsackievirus, echovirus, influenza, COVID-19

• Bacterial: Tuberculosis (important in endemic regions), staphylococci, streptococci

• Post–myocardial injury: Early post-MI, Dressler syndrome

• Autoimmune: SLE, rheumatoid arthritis

• Metabolic: Uremia

• Neoplastic: Lung, breast, lymphoma

• Drug-induced and radiation-related


Clinical Presentation


Chest Pain

• Sharp, pleuritic chest pain

• Worse on inspiration and lying supine

• Relieved by sitting up and leaning forward

• May radiate to neck, shoulder, or trapezius ridge


Associated Symptoms

• Low-grade fever

• Dyspnea (especially if effusion present)

• Palpitations

• Fatigue


Physical Examination


Pericardial Friction Rub

• High-pitched, scratchy sound

• Best heard at left lower sternal border

• Louder with patient leaning forward

• Pathognomonic but transient


Diagnostic Criteria


Diagnosis requires at least two of the following four criteria:


1. Typical chest pain



2. Pericardial friction rub



3. Typical ECG changes



4. New or worsening pericardial effusion




Investigations


Electrocardiogram

Classic ECG evolves through four stages:

Stage 1: Diffuse concave ST elevation with PR depression

Stage 2: ST normalization

Stage 3: T-wave inversion

Stage 4: ECG normalization


Key ECG Clues

• ST elevation is diffuse (not territorial)

• PR depression in multiple leads

• No reciprocal ST depression (except aVR, V1)


Laboratory Tests

• Elevated CRP and ESR

• Mild leukocytosis

• Troponin may be mildly elevated (myopericarditis)


Echocardiography

• Assesses presence and size of pericardial effusion

• Evaluates hemodynamic compromise

• Essential to exclude cardiac tamponade


Advanced Imaging

• Cardiac MRI: Detects pericardial inflammation and edema

• CT chest: Useful in suspected neoplastic or tuberculous disease


Differential Diagnosis

• Acute myocardial infarction

• Pulmonary embolism

• Aortic dissection

• Pleuritis

• Gastroesophageal reflux disease


Risk Stratification


High-Risk Features (Require Hospital Admission)

• Fever >38°C

• Subacute onset

• Large pericardial effusion

• Cardiac tamponade

• Immunosuppression

• Trauma

• Failure to respond to NSAIDs

• Elevated troponin (myopericarditis)


Management


First-Line Therapy

NSAIDs

• Ibuprofen 600–800 mg three times daily

• Aspirin preferred post-MI (750–1000 mg three times daily)

• Continue until symptom resolution and CRP normalization


Colchicine

• 0.5 mg once daily (<70 kg)

• 0.5 mg twice daily (≥70 kg)

• Duration: 3 months

• Reduces recurrence by ~50%


Gastroprotection

• Proton pump inhibitor with NSAIDs


Second-Line Therapy

Corticosteroids

• Reserved for refractory cases or contraindications to NSAIDs

• Low dose prednisone (0.2–0.5 mg/kg/day)

• Associated with higher recurrence rates


Treatment of Specific Causes

• Tuberculous pericarditis: Anti-TB therapy ± steroids

• Bacterial pericarditis: IV antibiotics and drainage

• Uremic pericarditis: Intensified dialysis


Activity Restriction

• Avoid strenuous activity until symptom and CRP resolution

• Athletes: Minimum restriction of 3 months


Complications

• Pericardial effusion

• Cardiac tamponade

• Recurrent pericarditis

• Constrictive pericarditis (rare in acute viral cases)


Prognosis

Overall prognosis is excellent in idiopathic and viral pericarditis. Most patients recover completely with appropriate therapy. Recurrence occurs in 15–30% without colchicine and significantly less with its use.


Guideline Perspective

Management recommendations are based on the European Society of Cardiology guidelines, emphasizing NSAIDs plus colchicine as standard first-line therapy and risk-based hospitalization.


Key Takeaway

Acute pericarditis is a clinical diagnosis supported by ECG and imaging. Early recognition, correct differentiation from myocardial infarction, and guideline-directed therapy ensure excellent outcomes and prevent recurrence.


drmusmanjaved.com

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...